Here are the 10-K annual reports from Mirion Technologies, Inc. (MIR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow MIR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MIR filings page.
Mirion Technologies, Inc. provides an in-depth annual overview of its nuclear and medical radiation safety businesses, global footprint and risk profile. The company operates through Nuclear & Safety and Medical segments, serving nuclear power plants, defense, laboratories, hospitals and cancer centers worldwide.
Mirion reports remaining performance obligations of $1,104.3 million and deferred contract revenue of $112.3 million as of December 31, 2025, with about 49% expected to turn into revenue in 2026. Research and development expenses were $38.9 million in 2025, supporting a 534-person R&D team.
The company notes net income of $29.8 million in 2025 versus prior-year losses and an accumulated deficit of $512.7 million. It highlights growth opportunities in small modular reactors, cancer care, dosimetry services and software, alongside detailed risk factors including geopolitical tensions, supply chain challenges, long sales cycles, fixed-price contracts and extensive regulatory oversight.